Sonire Therapeutics

About:

Sonire Therapeutics provides high-intensity focused ultrasound treatment for cancer.

Website: https://www.sonire-therapeutics.com/

Top Investors: Mitsubishi UFJ Capital, SBI Investment, Japan Science and Technology Agency, Higin Capital, Fast Track Initiative, Inc.

Description:

SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a novel therapeutic modality with the goal of giving cancer patients and their families a new future.

Total Funding Amount:

530M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Shinjuku, Yamanashi, Japan

Founded Date:

2020-02-01

Contact Email:

info(AT)sonire-t.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2021-06-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai